NORTH CHICAGO, Ill. , June 1, 2015 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Jefferies 2015 Healthcare Conference on Thursday, June 4, 2015 . Richard A. Gonzalez , chairman and chief executive officer, will participate in a question and answer session at 8:30 a.m. Central time .

- Acquisition will accelerate AbbVie's sales and earnings growth and further diversify its revenue base. AbbVie continues to expect the acquisition to be accretive beginning in 2017. - Broadens and deepens AbbVie's already robust pipeline, establishing the company as an emerging leader in the

NORTH CHICAGO, Ill. , May 13, 2015 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the UBS Global Healthcare Conference on Wednesday, May 20, 2015 . Bill Chase , executive vice president and chief financial officer, will participate in a question and answer session at 9 a.m. Central time .

NORTH CHICAGO, Ill. , May 6, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Bank of America Merrill Lynch 2015 Health Care Conference on Wednesday, May 13, 2015 . Richard A. Gonzalez , chairman and chief executive officer, will participate in a question and answer session at 3

NORTH CHICAGO, Ill. , April 29, 2015 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Deutsche Bank 40 th Annual Health Care Conference on Wednesday, May 6, 2015 . Bill Chase , executive vice president and chief financial officer, will participate in a question and answer session at

- Reports First-Quarter Adjusted EPS of $0.94, Up 32.4 Percent and Exceeding Previous Guidance Range of $0.82 to $0.84 (Reports GAAP EPS of $0.63) - Delivers First-Quarter Revenue of $5.040 Billion, an Increase of 17.8 Percent Over First-Quarter 2014 on an Operational Basis (Up 10.5 Percent on a

NORTH CHICAGO, Ill. , April 17, 2015 /PRNewswire/ -- AbbVie Inc. (" AbbVie ") (NYSE / CHX / Euronext Paris / SIX: ABBV) today announced that it has extended the expiration of its exchange offer to acquire all of the outstanding shares of common stock of Pharmacyclics, Inc. to 5 p.m.

NORTH CHICAGO, Ill. , April 15, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its first-quarter 2015 financial results on Thursday, April 23, 2015 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).

NORTH CHICAGO, Ill. , March 6, 2015 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Barclays Global Health Care Conference on Thursday, March 12, 2015 . Richard A. Gonzalez , chairman and chief executive officer, will participate in a question and answer session at 8:30 a.m.

- Adds Imbruvica® a first in class BTK inhibitor approved in multiple indications for blood cancers. - Extensive clinical program with over 50 studies ongoing evaluating Imbruvica® as a treatment for a wide range of additional indications, including early assessments for solid tumors and potential